Bora Pharmaceuticals Co., LTD. (TPE:6472)
Taiwan
· Delayed Price · Currency is TWD 873.00
+5.00 (0.58%)
Feb 21, 2025, 1:30 PM CST
TPE:6472 Revenue
Bora Pharmaceuticals Co., LTD. had revenue of 5.61B TWD in the quarter ending September 30, 2024, with 82.57% growth. This brings the company's revenue in the last twelve months to 16.71B, up 2.53% year-over-year. In the year 2023, Bora Pharmaceuticals Co., LTD. had annual revenue of 14.20B with 35.31% growth.
Revenue (ttm)
16.71B
Revenue Growth
+2.53%
P/S Ratio
5.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
90.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 14.20B | 3.71B | 35.31% |
| Dec 31, 2022 | 10.49B | 5.59B | 114.18% |
| Dec 31, 2021 | 4.90B | 3.10B | 172.28% |
| Dec 31, 2020 | 1.80B | 270.35M | 17.68% |
| Dec 31, 2019 | 1.53B | 156.79M | 11.42% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 44.43M |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |
| Center Laboratories | 1.57B |